These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 17295030)

  • 1. Complete factor H deficiency-associated atypical hemolytic uremic syndrome in a neonate.
    Cho HY; Lee BS; Moon KC; Ha IS; Cheong HI; Choi Y
    Pediatr Nephrol; 2007 Jun; 22(6):874-80. PubMed ID: 17295030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful plasma therapy for atypical hemolytic uremic syndrome caused by factor H deficiency owing to a novel mutation in the complement cofactor protein domain 15.
    Licht C; Weyersberg A; Heinen S; Stapenhorst L; Devenge J; Beck B; Waldherr R; Kirschfink M; Zipfel PF; Hoppe B
    Am J Kidney Dis; 2005 Feb; 45(2):415-21. PubMed ID: 15685522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome.
    Pérez-Caballero D; González-Rubio C; Gallardo ME; Vera M; López-Trascasa M; Rodríguez de Córdoba S; Sánchez-Corral P
    Am J Hum Genet; 2001 Feb; 68(2):478-84. PubMed ID: 11170895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Atypical hemolytic-uremic syndrome related to abnormalities within the complement system].
    Frémeaux-Bacchi V; Fakhouri F; Roumenina L; Dragon-Durey MA; Loirat C
    Rev Med Interne; 2011 Apr; 32(4):232-40. PubMed ID: 21376430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical hemolytic uremic syndrome.
    Loirat C; Frémeaux-Bacchi V
    Orphanet J Rare Dis; 2011 Sep; 6():60. PubMed ID: 21902819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of eculizumab and plasma exchange in successful combined liver-kidney transplantation in a case of atypical HUS associated with complement factor H mutation.
    Tran H; Chaudhuri A; Concepcion W; Grimm PC
    Pediatr Nephrol; 2014 Mar; 29(3):477-80. PubMed ID: 24221349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of plasma therapy in atypical hemolytic uremic syndrome with complement factor H mutations.
    Lapeyraque AL; Wagner E; Phan V; Clermont MJ; Merouani A; Frémeaux-Bacchi V; Goodship TH; Robitaille P
    Pediatr Nephrol; 2008 Aug; 23(8):1363-6. PubMed ID: 18425537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrano-proliferative glomerulonephritis, atypical hemolytic uremic syndrome, and a new complement factor H mutation: report of a case.
    Gnappi E; Allinovi M; Vaglio A; Bresin E; Sorosina A; Pilato FP; Allegri L; Manenti L
    Pediatr Nephrol; 2012 Oct; 27(10):1995-9. PubMed ID: 22669321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterozygous and homozygous factor h deficiencies associated with hemolytic uremic syndrome or membranoproliferative glomerulonephritis: report and genetic analysis of 16 cases.
    Dragon-Durey MA; Frémeaux-Bacchi V; Loirat C; Blouin J; Niaudet P; Deschenes G; Coppo P; Herman Fridman W; Weiss L
    J Am Soc Nephrol; 2004 Mar; 15(3):787-95. PubMed ID: 14978182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of function.
    Roumenina LT; Frimat M; Miller EC; Provot F; Dragon-Durey MA; Bordereau P; Bigot S; Hue C; Satchell SC; Mathieson PW; Mousson C; Noel C; Sautes-Fridman C; Halbwachs-Mecarelli L; Atkinson JP; Lionet A; Fremeaux-Bacchi V
    Blood; 2012 May; 119(18):4182-91. PubMed ID: 22246034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tailored eculizumab therapy in the management of complement factor H-mediated atypical hemolytic uremic syndrome in an adult kidney transplant recipient: a case report.
    Xie L; Nester CM; Reed AI; Zhang Y; Smith RJ; Thomas CP
    Transplant Proc; 2012 Dec; 44(10):3037-40. PubMed ID: 23195022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of atypical hemolytic uremic syndrome with a transient decrease in complement factor H.
    Hahn H; Um EY; Park YS; Cheong HI
    Pediatr Nephrol; 2006 Feb; 21(2):295-8. PubMed ID: 16362720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful therapeutic plasma exchange in a 3.2-kg body weight neonate with atypical hemolytic uremic syndrome.
    Jung S; Kang ES; Ki CS; Kim DW; Paik KH; Chang YS
    J Clin Apher; 2011; 26(3):162-5. PubMed ID: 21322001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative complement pathway assessment in patients with atypical HUS.
    Roumenina LT; Loirat C; Dragon-Durey MA; Halbwachs-Mecarelli L; Sautes-Fridman C; Fremeaux-Bacchi V
    J Immunol Methods; 2011 Feb; 365(1-2):8-26. PubMed ID: 21215749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma therapy for atypical haemolytic uraemic syndrome associated with heterozygous factor H mutations.
    Kim JJ; Goodship TH; Tizard J; Inward C
    Pediatr Nephrol; 2011 Nov; 26(11):2073-6. PubMed ID: 21717289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in proteins of the alternative pathway of complement and the pathogenesis of atypical hemolytic uremic syndrome.
    Abarrategui-Garrido C; Melgosa M; Peña-Carrión A; de Jorge EG; de Córdoba SR; López-Trascasa M; Sánchez-Corral P
    Am J Kidney Dis; 2008 Jul; 52(1):171-80. PubMed ID: 18423815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement dysfunction in hemolytic uremic syndrome.
    Zipfel PF; Skerka C
    Curr Opin Rheumatol; 2006 Sep; 18(5):548-55. PubMed ID: 16896298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome.
    Frémeaux-Bacchi V; Miller EC; Liszewski MK; Strain L; Blouin J; Brown AL; Moghal N; Kaplan BS; Weiss RA; Lhotta K; Kapur G; Mattoo T; Nivet H; Wong W; Gie S; Hurault de Ligny B; Fischbach M; Gupta R; Hauhart R; Meunier V; Loirat C; Dragon-Durey MA; Fridman WH; Janssen BJ; Goodship TH; Atkinson JP
    Blood; 2008 Dec; 112(13):4948-52. PubMed ID: 18796626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of defective complement control in hemolytic uremic syndrome.
    Zipfel PF; Misselwitz J; Licht C; Skerka C
    Semin Thromb Hemost; 2006 Mar; 32(2):146-54. PubMed ID: 16575689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interactive Factor H-atypical hemolytic uremic syndrome mutation database and website: update and integration of membrane cofactor protein and Factor I mutations with structural models.
    Saunders RE; Abarrategui-Garrido C; Frémeaux-Bacchi V; Goicoechea de Jorge E; Goodship TH; López Trascasa M; Noris M; Ponce Castro IM; Remuzzi G; Rodríguez de Córdoba S; Sánchez-Corral P; Skerka C; Zipfel PF; Perkins SJ
    Hum Mutat; 2007 Mar; 28(3):222-34. PubMed ID: 17089378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.